Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KDNY

Chinook Therapeutics (KDNY) Stock Price, News & Analysis

Chinook Therapeutics logo

About Chinook Therapeutics Stock (NASDAQ:KDNY)

Advanced Chart

Key Stats

Today's Range
$40.39
$40.39
50-Day Range
$38.66
$40.39
52-Week Range
$18.34
$40.51
Volume
N/A
Average Volume
1.19 million shs
Market Capitalization
$2.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KDNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chinook Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KDNY Stock News Headlines

Three Finalists Announced for the 2024 Bloom Burton Award
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
Chinook Elementary
Chinook Therapeutics, Inc. (KDNY)
Expert Ratings for Chinook Therapeutics
See More Headlines

KDNY Stock Analysis - Frequently Asked Questions

Chinook Therapeutics, Inc. (NASDAQ:KDNY) released its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.82) by $0.03. Chinook Therapeutics's quarterly revenue was down 32.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chinook Therapeutics investors own include Advanced Micro Devices (AMD), Meta Platforms (META), NIO (NIO), Ovintiv (OVV), Plug Power (PLUG), AMC Entertainment (AMC) and Applied Materials (AMAT).

Company Calendar

Last Earnings
5/09/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:KDNY
CIK
1435049
Fax
N/A
Employees
214
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$187.87 million
Net Margins
-4,199.93%
Pretax Margin
-4,115.56%
Return on Equity
-58.28%
Return on Assets
-44.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.82
Quick Ratio
5.82

Sales & Book Value

Annual Sales
$6.13 million
Price / Sales
473.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.91 per share
Price / Book
5.85

Miscellaneous

Outstanding Shares
71,810,000
Free Float
59,749,000
Market Cap
$2.90 billion
Optionable
Optionable
Beta
0.34
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:KDNY) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners